Comprehensive information about experimentally validated enhancers
| Enhancer ID: | E_04946 |
| Species: | Homo sapiens |
| Position : | chr14:72448647-72451627 |
| Year: | 2026 |
| Title: | Mendelian randomization facilitates identification of schizophrenia risk enhancer RNAs. |
| Genome Build: | hg19 |
| Enhancer Type: | Enhancer |
| Condition: | Disease |
| Disease Name: | Schizophrenia |
| PMID: | 41276612 |
| MONDO: | MONDO:0005090 |
| Tissue: | dorsolateral prefrontal cortex |
| Tissue Ontology ID: | UBERON:0009834 |
| Cell Source: | BrainSeq Phase 1 postmortem dorsolateral prefrontal cortex |
| Experiment Type: | Enhancer activity-associated transcription analysis; Genetic association analysis; eQTL analysis; Mendelian randomization analysis; Disease-variant functional analysis |
| High Throughput Method: | RNA-seq; SNP genotyping and imputation; cis-eQTL mapping; PGC3 schizophrenia GWAS integration; Summary-data-based Mendelian Randomization (SMR); eQTL analysis; GWAS |
| Low Throughput Method: | 3C |
| Target gene : | NA |
| TF name : | NA |
| Regulatory State : | Active |
| GeneName | Pathway Name | Source | Gene Number |
|---|
| Enhancer ID | Position | Tissue | Cell | Disease |
|---|---|---|---|---|
| E_04929 | chr14:72448647-72451627 | NA | neuroblastoma cell | Schizophrenia |